These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3964875)

  • 21. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ
    Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood group isoantigens and bladder cancer. An overview.
    Srinivas V; Khan SA
    Urol Int; 1985; 40(4):233-4. PubMed ID: 3901475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma.
    Borgström E; Wahren B
    Cancer; 1986 Dec; 58(11):2428-34. PubMed ID: 3768837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.
    Jakse G; Hofstädter F
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S74-8. PubMed ID: 6640839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.
    Coon JS; McCall A; Miller AW; Farrow GM; Weinstein RS
    Cancer; 1985 Aug; 56(4):797-804. PubMed ID: 4016671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoantigen ABH in cervical intraepithelial neoplasia.
    Lill PH; Norris HJ; Rubenstone AI; Chang-Lo M; Davidsohn I
    Am J Clin Pathol; 1976 Nov; 66(5):767-74. PubMed ID: 983985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors.
    Orlow I; Lacombe L; Pellicer I; Rabbani F; Delgado R; Zhang ZF; Szijan I; Cordón-Cardó C
    Int J Cancer; 1998 Mar; 75(6):819-24. PubMed ID: 9506524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder.
    Yamada T; Fukui I; Kobayashi T; Sekine H; Yokogawa M; Yamada T; Oshima H
    Cancer; 1991 Mar; 67(6):1661-6. PubMed ID: 2001555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABO(H) isoantigens in bladder tumors: a new technique of quantitative analysis.
    Srinivas V; Kiruluta HG
    J Urol; 1984 Feb; 131(2):245-8. PubMed ID: 6699953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence methods for measuring the A, B, and H isoantigens on cytological material from bladder carcinoma.
    Borgström E; Wahren B; Gustafson H
    Urol Res; 1985; 13(2):43-5. PubMed ID: 3892840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of 486P 3/12 antigen, ABO(H) blood group antigen and T antigen in cystectomy specimens from patients with stage T2 transitional cell carcinoma of the bladder.
    Heinzer H; Huland E; Mönk M; Huland H
    J Urol; 1992 Sep; 148(3):802-5. PubMed ID: 1512830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
    Proca E; Lucan M; Pîslăraşu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.
    Jakse G; Hofstädter F
    Urol Res; 1981; 9(3):153-6. PubMed ID: 7257030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
    Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
    Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
    [No Abstract]   [Full Text] [Related]  

  • 37. ABH blood group isoantigen expression in breast carcinomas--an immunohistochemical evaluation using monoclonal antibodies.
    Lee AK; DeLellis RA; Rosen PP; Saigo PE; Gangi MD; Bagin R; Groshen S; Wolfe HJ
    Am J Clin Pathol; 1985 Mar; 83(3):308-19. PubMed ID: 2579540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.
    Sheinfeld J; Reuter VE; Melamed MR; Fair WR; Morse M; Sogani PC; Herr HW; Whitmore WF; Cordon-Cardo C
    J Urol; 1990 Feb; 143(2):285-8. PubMed ID: 2405185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxidase antiperoxidase versus specific red cell adherence in detection of O (H) antigen in bladder cancer: a blind study.
    Javadpour N; Vafrier J; Worsham GF; O'Connel K
    J Surg Oncol; 1984 Oct; 27(2):112-5. PubMed ID: 6384666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.